FDA alerts and updates on the latest drug and device approvals, recalls, and other regulatory developments in ophthalmology.

Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...

Oculis Holding (OCS) added ~11% on Tuesday after the Swiss drug developer announced the breakthrough therapy designation for its eye disease therapy Privosegtor as a treatment for optic neuritis (ON), ...

There's a lot of drone warfare footage on the internet from Ukraine and Russia. But over the last year, a surprising evolution in the conflict has emerged, via photos from the battlefront posted ...

A nationwide cohort study of more than 4 million adults showed that people with allergic diseases were nearly one third more likely to develop optic neuritis than those without such conditions, with ...

Please provide your email address to receive an email when new articles are posted on . Being male or aged older than 40 years were consistently associated with poorer acute optic neuritis outcomes.

New research links two widely used diabetes drugs, semaglutide or tirzepatide, to a rare but potentially vision-threatening eye condition, raising questions about drug-specific risks and the need for ...

Both sides in the ongoing war in Ukraine are increasingly using fiber-optic drones, which are directly connected to their operator and cannot be jammed by electronic warfare methods. The Kalashnikov ...

Given the rapid pace of technological advancements on today’s battlefield (particularly in AI) understanding the capabilities of adaptive technologies and unmanned systems is imperative, especially ...